Stockholders' Equity (Tables)

9 Months Ended

May 31, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Recognized Stock-based Compensation Expense

The Company recognized stock-based compensation expense within selling, general and administrative expense as follows (in thousands):

	Three months ended				Nine months ended
	May 31, 2020		May 31, 2019		May 31, 2020		May 31, 2019
Restricted stock units	$	14,299	$	12,592	$	54,783	$	41,247
Employee stock purchase plan	2,583		1,914		7,431		6,205
Total	$	16,882	$	14,506	$	62,214	$	47,452

Schedule of Share-based Compensation Information

The following represents the stock-based compensation information for the period indicated (in thousands):

	Nine months ended
	May 31, 2020
Unrecognized stock-based compensation expense—restricted stock units	$	54,394
Remaining weighted-average period for restricted stock units expense	1.4 years

Schedule of Common Stock Outstanding

The following represents the common stock outstanding for the periods indicated:

	Three months ended				Nine months ended
	May 31, 2020		May 31, 2019		May 31, 2020		May 31, 2019
Common stock outstanding:
Beginning balances	151,407,526		152,878,329		153,520,380		164,588,172
Shares issued upon exercise of stock options	—		—		56,999		11,348
Shares issued under employee stock purchase plan	—		(215	)	595,717		692,110
Vesting of restricted stock	13,234		73,095		2,252,846		1,979,022
Purchases of treasury stock under employee stock plans	(2,808	)	(24,322	)	(619,931	)	(489,158	)
Treasury shares purchased(1)	(843,916	)	—		(5,231,975	)	(13,854,607	)
Ending balances	150,574,036		152,926,887		150,574,036		152,926,887

⁽¹⁾ 

In September 2019, the Company’s Board of Directors authorized the repurchase of up to $600.0 million of the Company’s common stock as part of a two-year capital allocation framework (the “2020 Share Repurchase Program”). As of May 31, 2020, 5.2 million shares had been repurchased for $188.9 million and $411.1 million remains available under the 2020 Share Repurchase Program.